Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Second-Line Therapy for RAS Wild-Type mCRC

April 16th 2015

Choosing Between VEGF and EGFR Targeted Therapy in mCRC

April 16th 2015

Newly Diagnosed mCRC Treatment Goals

April 16th 2015

The Genetic Landscape of Pancreatic Cancer

April 8th 2015

Early Diagnosis Challenging in Pancreatic Cancer

April 8th 2015

Treatment Approaches For Resectable Pancreatic Tumors

April 8th 2015

Treating Borderline Resectable/Locally Advanced Pancreatic Cancer

April 8th 2015

Treating Metastatic Pancreatic Cancer

April 8th 2015

The Role of Clinical Trials

April 8th 2015

Emerging Therapies and Future Treatment Approaches

April 8th 2015

Targeting the Tumor Microenvironment in Treating Pancreatic Cancer

April 8th 2015

Treating Pancreatic Neuroendocrine Tumors

April 8th 2015

Dr. James Fleshman on Minimally Invasive Surgery for Colorectal Cancer

April 8th 2015

James W. Fleshman Jr, MD, from the Department of Surgery and Internal Medicine at Baylor University Medical Center, discusses the surgical management of colorectal cancer.

Colorectal Cancer Management Requires Multidisciplinary Approach

April 7th 2015

In an interview with OncLive, James W. Fleshman Jr, MD, explained how technological advances and a growing commitment to a multidisciplinary approach have impacted the treatment of colorectal cancer.

FDA Label Update Emphasizes Importance of RAS Testing in mCRC

April 7th 2015

For further insight into the evolving role of expanded mutation analysis in mCRC, OncLive interviewed Marwan G. Fakih, MD, the director of Gastrointestinal Medical Oncology at City of Hope.

Challenges, Need for New Therapies Remain in HCC

April 6th 2015

To gain insight into the diagnosis and treatment of HCC, OncLive interviewed Laura Dawson, MD, FRCPC, a professor in the Department of Radiation Oncology at the University of Toronto.

Dr. Dawson on Increasing Causes and Unmet Needs in HCC

March 26th 2015

Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, discusses increasing cause of hepatocellular carcinoma (HCC) and unmet needs related to the disease.

GI Specialist Discusses Hurdles in Targeting Gastric Cancers

March 24th 2015

Alok A. Khorana, MD, specializes in predictive factors in gastrointestinal oncology and in cancer-associated thrombosis at the Cleveland Clinic. He provided insight on gastric cancer research in an interview with OncLive.

Controversies in Clinical Care: Questioning Research

March 23rd 2015

Maurie Markman, MD, offers examples of clinical trials where the interpretation of study results is worthy of considerable additional discussion or where justification for the actual conduct of the study can be called into question.

Targeting Gastric Cancer: Recent Advances Generate Fresh Hopes After Many Frustrations

March 11th 2015

As we enter an era of unprecedented clinical trial activity in gastric cancer, with thousands of patients enrolled or set to be enrolled in large, randomized phase III trials of novel targeted agents, we may finally be on the path to changing the course of this disease.